Inventor · disambiguated record
Marion Wienrich
Also filed as: WIENRICH MARION
5 granted patents·15 pending applications·68 citations·filing 1997–2024
78Inventor score
Files withBOEHRINGER INGELHEIM INT12BOEHRINGER INGELHEIM PHARMA3BOEHRINGER IMGELHEIM PHARMA KG1BOEHRINGER INGELHEIM KG1BOEHRINGER INGELHEIN INTERNAT1
Top patents by PatentIndex Score
20 records- 0184US2024277729A1Methods of treatment and pharmaceutical compositions using an sglt-2 inhibitor and a neuroleptic agentBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0277US6573276B2Muscarinic M1 agonist as an inhibitor of beta-amyloid (Aβ40 and Aβ42)-synthesisBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Jun 3, 2003·10 cites·13 claims
- 0374US2020222423A1Methods of treatment and pharmaceutical compositions using an sglt-2 inhibitor and a neuroleptic agentBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 0470US2021205324A1Methods of treatment and pharmaceutical compositions using an sglt-2 inhibitor and a neuroleptic agentBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 0569US6277872B1Oxadiazoles, processes for their preparation and their use as medicamentsBOEHRINGER INGELHEIM KG·Filed 1997·Granted Aug 21, 2001·33 cites·8 claims
- 0666US6255327B1Diphenyl-substituted heterocycles, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted Jul 3, 2001·24 cites·4 claims
- 0761US2018177794A1Methods of treatment and pharmaceutical compositions using an sglt-2 inhibitor and a neuroleptic agentBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 0856US2013137646A1Methods of treatment, pharmaceutical compositions and uses thereofWIENRICH MARION·Filed 2012·Application pending·0 cites
- 0954US6492407B2Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolonesBOEHRINGER IMGELHEIM PHARMA KG·Filed 2001·Granted Dec 10, 2002·1 cites·4 claims
- 1054US2016074415A1Methods of treatment and pharmaceutical compositions using an sglt-2 inhibitor and a neuroleptic agentBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 1150US2006004105A1Pharmaceutical composition for treating stress incontinence and/or mixed incontinenceBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 1249US2007129435A1Pharmaceutical Composition For Treating Stress Incontinence And/Or Mixed IncontinenceMICHEL MARTIN·Filed 2007·Application pending·0 cites
- 1348US2004266794A1Pramipexole for the reduction of excessive food intake for childrenBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 1447US2005261328A1Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agentsBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 1547US2009012161A9Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitorBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 1644US2005119239A1Pharmaceutical composition consisting of a beta-3-adrenoceptor agonist and an active substance which influences prostaglandin metabolismBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 1744US2005101607A1Pharmaceutical composition containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha reductase inhibitorBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 1843US2005154041A1Pharmaceutical composition consisting of a beta-3-adrenoceptor agonist and alpha-agonistBOEHRINGER INGELHEIN INTERNAT·Filed 2004·Application pending·0 cites
- 1938US2010081625A1Methods for preventing and treating neurodegenerative disordersBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 2027US6235738B1Diphenyl-substituted heterocycles with 6-membered ring, processes for the preparation thereof and the use thereof as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 1999·Granted May 22, 2001·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Marion Wienrich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →